Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

por Handelsman, Yehuda, Muskiet, Marcel H. A., Meneilly, Graydon S.
Publicado 2019

Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

por Handelsman, Yehuda, Muskiet, Marcel H. A., Meneilly, Graydon S.
Publicado 2019

Effects of dipeptidyl peptidase‐4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis...

por Kraaijenhof, Jordan, Muskiet, Marcel H. A., Tonneijck, Lennart, Ouwens, D. Margriet, Kramer, Mark H. H., van Raalte, Daniël H., Smits, Mark M.
Publicado 2020

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543–1556

por van Baar, Michaël J.B., van Ruiten, Charlotte C., Muskiet, Marcel H.A., van Bloemendaal, Liselotte, IJzerman, Richard G., van Raalte, Daniël H.
Publicado 2019

Renal sinus fat and renal hemodynamics: a cross-sectional analysis

por Spit, Karlinde A., Muskiet, Marcel H. A., Tonneijck, Lennart, Smits, Mark M., Kramer, Mark H. H., Joles, Jaap A., de Boer, Anneloes, van Raalte, Daniel H.
Publicado 2019

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in...

por Smits, Mark M, Tonneijck, Lennart, Muskiet, Marcel H A, Hoekstra, Trynke, Kramer, Mark H H, Pieters, Indra C, Cahen, Djuna L, Diamant, Michaela, van Raalte, Daniël H
Publicado 2015

Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study

por Bouman, Emma J., Smits, Mark M., van Bommel, Erik J., Muskiet, Marcel H. A., Hesp, Anne C., Serné, Erik H., Joles, Jaap A., van Raalte, Daniël H.
Publicado 2021

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

por Tonneijck, Lennart, Smits, Mark M., Muskiet, Marcel H. A., Hoekstra, Trynke, Kramer, Mark H. H., Danser, A. H. Jan, Diamant, Michaela, Joles, Jaap A., van Raalte, Daniël H.
Publicado 2016

Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients

por Smits, Mark M., Tonneijck, Lennart, Muskiet, Marcel H.A., Hoekstra, Trynke, Kramer, Mark H.H., Diamant, Michaela, Nieuwdorp, Max, Groen, Albert K., Cahen, Djuna L., van Raalte, Daniël H.
Publicado 2016

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placeb...

por Tonneijck, Lennart, Smits, Mark M., Muskiet, Marcel H.A., Hoekstra, Trynke, Kramer, Mark H.H., Danser, A.H. Jan, ter Wee, Piet M., Diamant, Michaela, Joles, Jaap A., van Raalte, Daniel H.
Publicado 2019

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT...

por Scholtes, Rosalie A., Muskiet, Marcel H.A., van Baar, Michiel J.B., Hesp, Anne C., Greasley, Peter J., Karlsson, Cecilia, Hammarstedt, Ann, Arya, Niki, van Raalte, Daniël H., Heerspink, Hiddo J.L.
Publicado 2021

Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefi...

por Muskiet, Marcel H. A., Tonneijck, Lennart, Smits, Mark M., Kramer, Mark H. H., Ouwens, D. Margriet, Hartmann, Bolette, Holst, Jens J., Danser, A. H. Jan, Joles, Jaap A., van Raalte, Daniël H.
Publicado 2021

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial

por Smits, Mark M., Tonneijck, Lennart, Muskiet, Marcel H. A., Kramer, Mark H. H., Pouwels, Petra J. W., Pieters-van den Bos, Indra C., Hoekstra, Trynke, Diamant, Michaela, van Raalte, Daniël H., Cahen, Djuna L.
Publicado 2016

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet...

por Scholtes, Rosalie A., Muskiet, Marcel H.A., van Baar, Michiel J.B., Hesp, Anne C., Greasley, Peter J., Hammarstedt, Ann, Karlsson, Cecilia, Hallow, Karen M., Danser, A.H. Jan, Heerspink, Hiddo J.L., van Raalte, Daniël H.
Publicado 2022

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

por Sivalingam, Suvanjaa, Larsen, Emil List, van Raalte, Daniel H., Muskiet, Marcel H. A., Smits, Mark M., Tonneijck, Lennart, Joles, Jaap A., von Scholten, Bernt Johan, Zobel, Emilie Hein, Persson, Frederik, Henriksen, Trine, Diaz, Lars Jorge, Hansen, Tine W., Poulsen, Henrik Enghusen, Rossing, Peter
Publicado 2021